结核病与肺部健康杂志 ›› 2018, Vol. 7 ›› Issue (3): 180-184.doi: 10.3969/j.issn.2095-3755.2018.03.007

• 论著 • 上一篇    下一篇

采用GenoType MTBDR plus检测技术快速检测结核分枝杆菌耐药性的研究

洪创跃,李金莉,赵广录,桂静,朱玉梅,王峰()   

  1. 518020 深圳市慢性病防治中心实验研究所
  • 收稿日期:2018-07-23 出版日期:2018-09-30 发布日期:2018-10-16
  • 通信作者: 王峰 E-mail:biowangfeng@163.com
  • 基金资助:
    深圳市卫生计生系统重点学科建设能力提升项目(201606044)

Rapid detection of Mycobacterium tuberculosis drug resistance by GenoType MTBDR plus assay

Chuang-yue HONG,Jin-li LI,Guang-lu ZHAO,Jing GUI,Yu-mei ZHU,Feng WANG()   

  1. Department of Research Institute Laboratory, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China
  • Received:2018-07-23 Online:2018-09-30 Published:2018-10-16
  • Contact: Feng WANG E-mail:biowangfeng@163.com

摘要:

目的 评价GenoType MTBDR plus方法[线性探针杂交技术(HAIN技术)中的一种方法,以下简称“HAIN技术”]检测深圳地区结核分枝杆菌菌株耐药性的临床应用能力。方法 采用HAIN技术检测2014—2016年深圳市耐药监测项目(来自于深圳市慢性病防治中心及深圳市各区慢性病防治院)的1140株临床菌株的耐药性,以传统药物敏感性试验(简称“药敏试验”)的比例法(简称“比例法药敏试验”)作为对照,评价HAIN技术检测耐药的能力。分别利用McNemar检验对检测效果进行评价,敏感度和特异度对检测结果真实性进行评价,阳性预测值和阴性预测值对检测方法应用价值进行评价,以及利用Kappa检验对两种方法检测结果的一致性进行评价。结果 比例法药敏试验检测结果为异烟肼耐药123例,利福平耐药75例,耐多药52例;HAIN技术检测异烟肼耐药120例、利福平耐药79例、耐多药52例,两种检测方法比较差异均无统计学意义(McNemar 检验,P值分别为0.250、0.219、1.000)。以比例法药敏试验结果为标准,HAIN技术检测异烟肼耐药的敏感度和特异度分别为97.6%(120/123)和100.0%(1017/1017),阳性预测值和阴性预测值分别为100.0%(120/120)和99.7%(1017/1020),Kappa值为0.986;检测利福平耐药的敏感度和特异度分别为98.7%(74/75)和99.5%(1060/1065),阳性预测值和阴性预测值分别为93.7%(74/79)和99.9%(1060/1061),Kappa值为0.958;检测耐多药的敏感度和特异度分别为96.2%(50/52)和99.8%(1086/1088),阳性预测值和阴性预测值分别为96.2%(50/52)和99.8%(1086/1088),Kappa值为0.960。HAIN技术检测利福平耐药基因rpoB发生频率最高的突变是野生型条带8缺失及S531L位点突变(58.7%,44/75),其次是野生型条带7缺失及H526Y位点突变(10.7%,8/75),以及单纯野生条带2缺失(10.7%,8/75);异烟肼耐药基因突变频率最高的是katG的野生条带1缺失及S315T1位点突变(70.8%,85/120),其次是inhA的野生条带1缺失及C15T位点突变(18.3%,22/120)。结论 HAIN技术是一种快速检测耐药结核病的诊断方法,对耐异烟肼和耐利福平有较高的敏感度和特异度,可用于临床结核病耐药的快速检测。

关键词: 分枝杆菌, 结核, 分子探针技术, 结核, 抗多种药物性, 评价研究(主题)

Abstract:

Objective To evaluate the ability of GenoType MTBDR plus assay (a linear probe hybridization technology, hereinafter referred to as “HAIN technology”) for detection of drug resistance in Mycobacterium tuberculosis in Shenzhen. Methods Using HAIN technology, the drug resistance of 1140 clinical isolates which were from Shenzhen Drug Resistance Monitoring Project in 2014-2016 (conducted in Shenzhen Center for Chronic Disease Control and Shenzhen District Chronic Disease Prevention and Treatment Institute) were tested. The traditional proportional drug susceptibility testing (DST) was used as standard to evaluate the capability of HAIN technology in detecting drug resistance. The McNemar test was used to compare the detection results. The sensitivity and specificity were used to evaluate the authenticity. The positive predictive value (PPV) and negative predictive value (NPV) were used to evaluate the application value of HAIN technology, and Kappa test was used to evaluate the consistency of the detection results of the two methods. Results The results of proportional DST showed that 123 and 75 cases were resistant to isoniazid and rifampicin, respectively, and 52 cases were resistant to multidrug. The HAIN technique detected 120 cases of isoniazid resistance, 79 cases of rifampicin resistance, and 52 cases of multidrug resistance (MDR). No significant difference was detected between the two methods (McNemar test, P values were 0.250, 0.219 and 1.000, respectively). Taking proportional DST as standard, the sensitivity and specificity of HAIN technique for the detection of isoniazid resistance were 97.6% (120/123) and 100.0% (1017/1017), the PPV and NPV were 100.0% (120/120) and 99.7% (1017/1020), and the Kappa value was 0.986. The sensitivity and specificity of HAIN technique for the detection of rifampin resistance were 98.7% (74/75) and 99.5% (1060/1065), the PPV and NPV were 93.7% (74/79) and 99.9% (1060/1061), and the Kappa value was 0.958. The sensitivity and specificity of HAIN technique for the detection of MDR were 96.2% (50/52) and 99.8% (1086/1088), the PPV and NPV were 96.2% (50/52) and 99.8% (1086/1088), and the Kappa value was 0.960. The results of HAIN technique demonstrated that the most frequent mutation in the rifampicin-resistant gene, rpoB was wild-type band 8 deletion and S531L site mutation (58.7%, 44/75), followed by wild-type band 7 deletion and H526Y site mutation (10.7%, 8/75) and wild-type band 2 deletion (10.7%, 8/75); the most frequent mutation in the isoniazid-resistant genes was wild-type band 1 deletion and S315T1 site mutation in katG (70.8%, 85/120), followed by wild-type band 1 deletion and C15T site mutation in inhA (18.3%, 22/120). Conclusion With its high sensitivity and specificity, GenoType MTBDR plus assay (HAIN technology) is a promising rapid method to detect isoniazid and rifampicin resistance in Mycobacterium tuberculosis strains.

Key words: Mycobacterium tuberculosis, Molecular probe techniques, Tuberculosis, multidrug-resistant, Evaluation studies as topic